iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Large Decrease in Short Interest

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,800 shares, a decline of 85.2% from the May 15th total of 12,200 shares. Based on an average trading volume of 1,100 shares, the days-to-cover ratio is presently 1.6 days. Approximately 1.2% of the shares of the company are sold short.

iShares Neuroscience and Healthcare ETF Trading Down 2.3%

Shares of NYSEARCA IBRN opened at $22.86 on Friday. iShares Neuroscience and Healthcare ETF has a 12 month low of $17.86 and a 12 month high of $28.74. The stock has a 50 day moving average of $21.75 and a 200-day moving average of $23.90. The company has a market capitalization of $3.43 million, a P/E ratio of 15.90 and a beta of 0.71.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.